Interrelation between programmed cell death and immunogenic cell death: take antitumor nanodrug as an example
Programmed cell death (PCD, mainly including apoptosis, necrosis, ferroptosis, pyroptosis,
and autophagy) and immunogenic cell death (ICD), as important cell death mechanisms, are …
and autophagy) and immunogenic cell death (ICD), as important cell death mechanisms, are …
Camptothecin-based prodrug nanomedicines for cancer therapy
R Zhang, J Yu, Z Guo, H Jiang, C Wang - Nanoscale, 2023 - pubs.rsc.org
Camptothecin (CPT) is a cytotoxic alkaloid that attenuates the replication of cancer cells via
blocking DNA topoisomerase 1. Despite its encouraging and wide-spectrum antitumour …
blocking DNA topoisomerase 1. Despite its encouraging and wide-spectrum antitumour …
Assembly drives regioselective azide-alkyne cycloaddition reaction
Q Jiang, W Zhan, X Liu, L Bai, M Wang, Y Xu… - Nature …, 2023 - nature.com
Azide-alkyne cycloaddition reaction is a very common organic reaction to synthesize
nitrogen-containing heterocycles. Once catalyzed by Cu (I) or Ru (II), it turns out to be a click …
nitrogen-containing heterocycles. Once catalyzed by Cu (I) or Ru (II), it turns out to be a click …
In situ transformable nanoplatforms with supramolecular cross‐linking triggered complementary function for enhanced cancer photodynamic therapy
In vivo cross‐linking of nanoparticles is widely used to increase accumulation of therapeutic
agents at tumor site for enhanced therapy. However, the components in nanoplatforms …
agents at tumor site for enhanced therapy. However, the components in nanoplatforms …
Tandem Guest‐Host‐Receptor Recognitions Precisely Guide Ciprofloxacin to Eliminate Intracellular Staphylococcus aureus
Staphylococcus aureus (S. aureus) is able to hide within host cells to escape immune
clearance and antibiotic action, causing life‐threatening infections. To boost the therapeutic …
clearance and antibiotic action, causing life‐threatening infections. To boost the therapeutic …
Nanomedicine-mediated regulated cell death in cancer immunotherapy
Y Sun, T Lian, Q Huang, Y Chang, Y Li, X Guo… - Journal of Controlled …, 2023 - Elsevier
Immunotherapy has attracted widespread attention in cancer treatment and has achieved
considerable success in the clinical treatment of some tumors, but it has a low response rate …
considerable success in the clinical treatment of some tumors, but it has a low response rate …
Transformable Supramolecular Self‐Assembled Peptides for Cascade Self‐Enhanced Ferroptosis Primed Cancer Immunotherapy
H Wang, D Jiao, D Feng, Q Liu, Y Huang… - Advanced …, 2024 - Wiley Online Library
Immunotherapy has received widespread attention for its effective and long‐term tumor‐
eliminating ability. However, for immunogenic “cold” tumors, such as prostate cancer (PCa) …
eliminating ability. However, for immunogenic “cold” tumors, such as prostate cancer (PCa) …
Evaluating Alkaline Phosphatase-Instructed Self-Assembly of d-Peptides for Selectively Inhibiting Ovarian Cancer Cells
Cancer is a major public health concern requiring novel treatment approaches. Enzyme-
instructed self-assembly (EISA) provides a unique approach for selectively inhibiting cancer …
instructed self-assembly (EISA) provides a unique approach for selectively inhibiting cancer …
Ultrathin 2D Pd/Cu Single‐Atom MOF Nanozyme to Synergistically Overcome Chemoresistance for Multienzyme Catalytic Cancer Therapy
X Guan, X Ge, H Dong, J Wei… - Advanced Healthcare …, 2023 - Wiley Online Library
Single‐atom nanozymes (SAzymes) have obtained increasing interest to mimic natural
enzymes for efficient cancer therapy, while challenged by chemoresistance from cellular …
enzymes for efficient cancer therapy, while challenged by chemoresistance from cellular …
MC1R Peptide Agonist Self-Assembles into a Hydrogel That Promotes Skin Pigmentation for Treating Vitiligo
C Zhu, T Li, Z Wang, Z Li, J Wei, H Han, D Yuan… - ACS …, 2023 - ACS Publications
Vitiligo, a common skin disease that seriously affects 0.5–2.0% of the worldwide population,
lacks approved therapeutics due to a wide range of adverse side effects. As a key regulator …
lacks approved therapeutics due to a wide range of adverse side effects. As a key regulator …